Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity

British Journal of Pharmacology

Volumn 169, Issue 6, 2013, Pages 1290-1304

  Anderson, U A ^a   Carson, C ^a   Johnston, L ^a   Joshi, S ^b   Gurney, A M ^b   McCloskey, K D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

contractility; electrophysiology; immunohistochemistry; potassium channels; smooth muscle; urinary bladder

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; CHROMANOL 293B; FLUPIRTINE; LINOPIRDINE; MECLOFENAMIC ACID; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; POTASSIUM CHANNEL KCNQ4; POTASSIUM CHANNEL KCNQ5; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL CELL; ARTICLE; BLADDER CONTRACTION; BLADDER MUSCLE; CALCIUM IMAGING; CELL LEVEL; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DETRUSOR MUSCLE; GENETICS; IMAGING; IMMUNOFLUORESCENCE; MEMBRANE STEADY POTENTIAL; MYOGRAPHY; NONHUMAN; PATCH CLAMP; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TISSUE LEVEL;

ANIMALS; ANIMALS, INBRED STRAINS; CALCIUM SIGNALING; CELLS, CULTURED; ELECTROPHYSIOLOGICAL PHENOMENA; GENE EXPRESSION; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; KCNQ POTASSIUM CHANNELS; MALE; MEMBRANE POTENTIALS; MEMBRANE TRANSPORT MODULATORS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOGRAPHY; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; PROTEIN ISOFORMS; SINGLE-CELL ANALYSIS; URINARY BLADDER;

EID: 84879373743     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12210     Document Type: Article

References (67)

1. Aiken SP, Lampe BJ, Murphy PA, Brown BS, (1995). Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer. Br J Pharmacol 115: 1163-1168.
2. Alexander SP, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. Anderson UA, Carson C, McCloskey KD, (2009). KCNQ currents and their contribution to resting membrane potential and the excitability of interstitial cells of Cajal from the guinea pig bladder. J Urol 182: 330-336.
4. + channels. Br J Pharmacol 153: 1259-1271.
5. + channels in murine urinary bladder smooth muscle. BJU Int 102: 113-124.
6. Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ, et al. (1998). A potassium channel mutation in neonatal human epilepsy. Science 279: 403-406.
7. + channel blocker 293B. Pflugers Arch 434: 499-501.
8. Bonev AD, Nelson MT, (1993). ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder. Am J Physiol 264: C1190-C2000.
9. Brown DA, Passmore GM, (2009). Neural KCNQ (Kv7) channels. Br J Pharmacol 156: 1185-1195.
10. Busch AE, Suessbrich H, Waldegger S, Sailer E, Greger R, Lang H, et al. (1996). Inhibition of IKs in guinea pig cardiac myocytes and guinea pig IsK channels by the chromanol 293B. Pflugers Arch 432: 1094-1096.
11. Carson C, McCloskey KD, (2007). Potassium channels and spontaneous activity in guinea-pig bladder. Proc Life Sciences PC572.
12. Costa AM, Brown BS, (1997). Inhibition of M-current in cultured rat superior cervical ganglia by linopirdine: mechanism of action studies. Neuropharmacology 36: 1747-1753.
13. Delmas P, Brown DA, (2005). Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 6: 850-862.
14. Evans AM, Osipenko ON, Gurney AM, (1996). Properties of a novel K+ current that is active at resting potential in rabbit pulmonary artery smooth muscle cells. J Physiol 496: 407-420.
15. Friedel HA, Fitton A, (1993). Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs 45: 548-569.
16. Gu N, Vervaeke K, Hu H, Storm JF, (2005). Kv7/KCNQ/M and HCN/h, but not KCa2/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells. J Physiol 566: 689-715.
17. Hadley JK, Noda M, Selyanko AA, Wood IC, Abogadie FC, Brown DA, (2000). Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels. Br J Pharmacol 129: 413-415.
18. Hashitani H, Brading AF, (2003). Ionic basis for the regulation of spontaneous excitation in detrusor smooth muscle cells of the guinea-pig urinary bladder. Br J Pharmacol 140: 159-169.
19. 2+ channels and ryanodine receptors in guinea-pig urinary bladder myocytes. J Physiol 541: 483-492.
20. + current during depolarization in smooth muscle cells of the guinea-pig vas deferens and urinary bladder. J Physiol 510: 705-719.
21. Jentsch TJ, (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 1: 1-30.
22. Jepps TA, Greenwood IA, Moffatt JD, Sanders KM, Ohya S, (2009). Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles. Am J Physiol Gastrointest Liver Physiol 297: G107-G115.
23. Joshi S, Balan P, Gurney AM, (2006). Pulmonary vasoconstrictor action of KCNQ potassium channel blockers. Respir Res 7: 1-10.
24. Joshi S, Sedivy V, Hodyc D, Herget J, Gurney AM, (2009). KCNQ modulators reveal a key role for KCNQ potassium channels in regulating the tone of rat pulmonary artery smooth muscle. J Pharmacol Exp Ther 329: 368-376.
25. Kapetanovic IM, Yonekawa WD, Kupferberg HJ, (1995). The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro. Epilepsy Res 22: 67-73.
26. + channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc Natl Acad Sci U S A 97: 4333-4338.
27. Kubisch C, Schroeder BC, Friedrich T, Lütjohann B, El-Amraoui A, Marlin S, et al. (1999). and Jentsch TJ KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96: 437-446.
28. Lamas JA, Selyanko AA, Brown DA, (1997). Effects of a cognition-enhancer, linopirdine (DuP 996), on M-type potassium currents (IK(M)) and some other voltage- and ligand-gated membrane currents in rat sympathetic neurons. Eur J Neurosci 9: 605-616.
29. Liang GH, Jin Z, Ulfendahl M, Järlebark L, (2006). Molecular analyses of KCNQ1-5 potassium channel mRNAs in rat and guinea pig inner ears: expression, cloning, and alternative splicing. Acta Otolaryngol 126: 6-52.
30. McCallum LA, Greenwood IA, Tribe RM, (2009). Expression and function of K(v)7 channels in murine myometrium throughout oestrous cycle. Pflugers Arch 457: 1111-1120.
31. McCloskey KD, Gurney AM, (2002). Kit positive cells in the guinea pig bladder. J Urol 168: 832-836.
32. Mackie AR, Brueggemann LI, Henderson KK, Shiels AJ, Cribbs LL, Scrogin KE, et al. (2008). Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin. J Pharmacol Exp Ther 325: 475-483.
33. Main MJ, Cryan JE, Dupere JR, Cox B, Clare JJ, Burbidge SA, (2000). Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol 58: 53-62.
34. Martire M, Castaldo P, D'Amico M, Preziosi P, Annunziato L, Taglialatela M, (2004). M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. J Neurosci 24: 592-597.
35. Miceli F, Soldovieri MV, Martire M, Taglialatela M, (2008). Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr Opin Pharmacol 8: 65-74.
36. + channels in mouse urinary bladder smooth muscle cells. Jpn J Pharmacol 84: 97-100.
37. Ohya S, Asakura K, Muraki K, Watanabe M, Imaizumi Y, (2002). Molecular and functional characterization of ERG, KCNQ, and KCNE subtypes in rat stomach smooth muscle. Am J Physiol Gastrointest Liver Physiol 282: G277-G287.
38. Ohya S, Sergeant GP, Greenwood IA, Horowitz B, (2003). Molecular variants of KCNQ channels expressed in murine portal vein myocytes. Circ Res 92: 1016-1023.
39. Peretz A, Nachman R, Uziyel Y, Gibor G, Shabat D, Attali B, (2005). Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol Pharmacol 67: 1053-1066.
40. Petkov GV, (2011). Role of potassium ion channels in detrusor smooth muscle function and dysfunction. Nat Rev Urol 9: 30-40.
41. + channel regulates contractile activity of mouse urinary bladder smooth muscle. J Physiol 537: 443-452.
42. Petkov GV, Heppner TJ, Bonev AD, Herrera GM, Nelson MT, (2001b). Low levels of K(ATP) channel activation decrease excitability and contractility of urinary bladder. Am J Physiol Regul Integr Comp Physiol 280: R1427-R1433.
43. + currents in vestibular hair cells. Am J Physiol Cell Physiol 280: C473-C480.
44. Robbins J, (2001). KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol Ther 90: 1-19.
45. Rode F, Svalø J, Sheykhzade M, Rønn LC, (2010). Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder. Eur J Pharmacol 638: 121-127.
46. Romey G, Attali B, Chouabe C, Abitbol I, Guillemare E, Barhanin J, et al. (1997). Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity. J Biol Chem 272: 16713-16716.
47. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, et al. (1996). Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384: 80-83.
48. Schroeder BC, Kubisch C, Stein V, Jentsch TJ, (1998). Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature 396: 687-690.
49. Schroeder BC, Hechenberger M, Weinreich F, Kubisch C, Jentsch TJ, (2000). KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-currents. J Biol Chem 275: 24089-24095.
50. Seebohm G, Pusch M, Chen J, Sanguinetti MC, (2003). Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels. Circ Res 93: 941-947.
51. Selyanko AA, Hadley JK, Brown DA, (2001). Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells. J Physiol 534: 15-24.
52. Shah MM, Mistry M, Marsh SJ, Brown DA, Delmas P, (2002). Molecular correlates of the M-current in cultured rat hippocampal neurons. J Physiol 544: 29-37.
53. Søgaard R, Ljungstrøm T, Pedersen KA, Olesen SP, Jensen BS, (2001). KCNQ4 channels expressed in mammalian cells: functional characteristics and pharmacology. Am J Physiol Cell Physiol 280: C859-C866.
54. + channel (KCNQ) opener retigabine in freely moving, conscious rats. J Urol 172: 2054-2058.
55. Suessbrich H, Bleich M, Ecke D, Rizzo M, Waldegger S, Lang F, et al. (1996). Specific blockade of slowly activating I(sK) channels by chromanols-impact on the role of I(sK) channels in epithelia. FEBS Lett 396: 271-275.
56. Svalø J, Hansen HH, Rønn LC, Sheykhzade M, Munro G, Rode F, (2011). Kv7 positive modulators reduce detrusor overactivity and increase bladder capacity in rats. Basic Clin Pharmacol Toxicol 110: 145-153.
57. Tatulian L, Delmas P, Abogadie FC, Brown DA, (2001). Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci 21: 5535-5545.
58. + current. J Physiol 549: 65-74.
59. Turner WH, Brading AF, (1997). Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis and treatment. Pharmacol Ther 75: 77-110.
60. Vervaeke K, Gu N, Agdestein C, Hu H, Storm JF, (2006). Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release. J Physiol 576: 235-256.
61. Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, et al. (1998). KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282: 1890-1893.
62. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, et al. (1996). Positional cloning of a novel potassium channel gene: KvLQT1 mutations cause cardiac arrhythmias. Nat Genet 12: 17-23.
63. Wladyka CL, Kunze DL, (2006). KCNQ/M-currents contribute to the resting membrane potential in rat visceral sensory neurons. J Physiol 575: 175-189.
64. Wuttke TV, Seebohm G, Bail S, Maljevic S, Lerche H, (2005). The new Anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol 67: 1009-1017.
65. Yeung SY, Pucovský V, Moffatt JD, Saldanha L, Schwake M, Ohya S, et al. (2007). Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity. Br J Pharmacol 151: 758-770.
66. Yeung SYM, Greenwood IA, (2005). Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells. Br J Pharmacol 146: 585-595.
67. Zaczek R, Chorvat RJ, Saye JA, Pierdomenico ME, Maciag CM, Logue AR, et al. (1998). Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4- pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. J Pharmacol Exp Ther 285: 724-730.